1987
DOI: 10.1016/s0022-3468(87)80107-0
|View full text |Cite
|
Sign up to set email alerts
|

Experience with renal failure during extracorporeal membrane oxygenation: Treatment with continuous hemofiltration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
0

Year Published

1993
1993
2015
2015

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(24 citation statements)
references
References 7 publications
0
24
0
Order By: Relevance
“…3,4 Diuretic therapy and renal replacement therapy are not uncommon in this setting, further complicating the fluid and electrolyte management of these patients. [5][6][7] Increases in atrial natriuretic hormone and plasmin renin activity have also been observed and quantified during ECMO. 2 Visser and de Jong 8 demonstrated that leakage from the membrane oxygenator was dependent on the type of hollowfiber membrane.…”
mentioning
confidence: 99%
“…3,4 Diuretic therapy and renal replacement therapy are not uncommon in this setting, further complicating the fluid and electrolyte management of these patients. [5][6][7] Increases in atrial natriuretic hormone and plasmin renin activity have also been observed and quantified during ECMO. 2 Visser and de Jong 8 demonstrated that leakage from the membrane oxygenator was dependent on the type of hollowfiber membrane.…”
mentioning
confidence: 99%
“…Acute renal failure and the consequences of this organ dysfunction, such as hypervolemia, hyperkalemia, or azotemia, are indications for continuous hemofiltration placed in-line with the ECMO circuit (59).…”
Section: Complicationsmentioning
confidence: 99%
“…For this reason, feeding with breastmilk is recommended for newborns with AKI. Significant elevations in serum phosphate represent a risk of development of extraskeletal calcifications of the heart, blood vessels, and kidneys in the newborn, especially when the calcium-phosphorus product exceeds 70 (23). Calcium carbonate may be used as a phosphate-binding agent in infants whose phosphorous intake exceeds excretion.…”
Section: Management Medical Managementmentioning
confidence: 99%